1. Adelaide Research & Scholarship

Browsing "Pharmacology" by Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 512 to 531 of 918 < previous   next >
PreviewIssue DateTitleAuthor(s)
2011Magnesium and stressCuciureanu, M.; Vink, R.; Vink, R.; Nechifor, M.
2012Maintenance drugs to treat opioid dependenceFarrell, M.; Wodak, A.; Gowing, L.
2006Maintenance pharmacotherapy for opioid dependence and SF-36 Health status: a comparison with general population norms and other chronic disordersO'Brien, S.; Mattick, R.; White, J.; Breen, C.; Kimber, J.; Ritter, A.; Lintzeris, N.
1998Management issues associated with constructed wetlands in urban areas of Australia.Williams, W.; Pettman, I.; Manning, P.; Falconer, I.
1996Management of isolated systolic hypertensionTonkin, A.; Wing, L.
2011Marked decline in 3,4-methylenedioxymethamphetamine (MDMA) based on wastewater analysisChen, C.; Kostakis, C.; Harpas, P.; Felgate, P.; Irvine, R.; White, J.
2013Mass or molar? Recommendations for reporting concentrations of therapeutic drugsJones, G.; Bryant, S.; Fullinfaw, R.; Ilett, K.; Miners, J.; Morris, R.; Doogue, M.
2011Measurement of Cyclosporine A in rat tissues and human kidney transplant biopsies - A method suitable for small (<1 mg) samplesNoll, B.; Coller, J.; Somogyi, A.; Morris, R.; Russ, G.; Hesselink, D.; van Gelder, T.; Sallustio, B.
2008Measuring the unbound concentration fails to resolve analytic interferences in digoxin immunoassaysMorris, R.; Jones, T.; Wicks, F.; Rogers, N.
1999Mechanisms of fatal opioid overdose.White, J.; Irvine, R.
2013Medication-overuse headache and opioid-induced hyperalgesia: A review of mechanisms, a neuroimmune hypothesis and a novel approach to treatmentJohnson, J.; Hutchinson, M.; Williams, D.; Rolan, P.
2021Medication-related hospital admissions in aged care residentsKalisch Ellett, L.M.; Kassie, G.M.; Caughey, G.E.; Pratt, N.L.; Ramsay, E.N.; Roughead, E.E.
1995Medicinal mishapsTaverner, D.; Marley, J.
2013Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine releaseRickhag, M.; Owens, W.; Winkler, M.; Strandfelt, K.; Rathje, M.; Sorensen, G.; Andresen, B.; Madsen, K.; Jorgensen, T.; Wortwein, G.; Woldbye, D.; Sitte, H.; Daws, L.; Gether, U.
2013Methadone at tapered doses for the management of opioid withdrawalAmato, L.; Davoli, M.; Minozzi, S.; Ferroni, E.; Ali, R.; Ferri, M.
2012Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjectsGelston, E.; Coller, J.; Lopatko, O.; James, H.; Schmidt, H.; White, J.; Somogyi, A.
2001Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphineDoverty, M.; Somogyi, A.; White, J.; Bochner, F.; Beare, C.; Menelaou, A.; Ling, W.
2006Methadone maintenance patients are cross-tolerant to the antinociceptive effects of very high plasma morphine concentrationsAthanasos, P.; Smith, C.; White, J.; Somogyi, A.; Bochner, F.; Ling, W.
1999Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4.Foster, D.; Somogyi, A.; Bochner, F.
2006Methadone treatment of injecting opioid users for prevention of HIV infectionGowing, L.; Farrell, M.; Bornemann, R.; Sullivan, L.; Ali, R.
Showing results 512 to 531 of 918 < previous   next >